Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan M Fogelman

Showing results (51-60 of 149) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2004
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse modelsSrinivasa T Reddy, Julie T Nguyen, Victor Grijalva, et al.
Journal of Clinical Lipidology|May 2, 2008
Peptide Mimetics of Apolipoproteins Improve HDL FunctionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Diabetes|August 20, 2011
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetesCecilia Morgantini, Andrea Natali, Beatrice Boldrini, et al.
Journal of Lipid Research|December 15, 2011
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null miceMohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, et al.
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Mechanisms of disease: proatherogenic HDL--an evolving fieldMohamad Navab, Gattadahalli M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Multiple indications for anti-inflammatory apolipoprotein mimetic peptidesBrian J Van Lenten, Mohamad Navab, G M Anantharamaiah, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2012
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer modelFeng Gao, Arnab Chattopadhyay, Mohamad Navab, et al.
The Journal of Biological Chemistry|May 13, 2009
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoproteinJunji Watanabe, Victor Grijalva, Susan Hama, et al.
Circulation|January 24, 2002
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterolMohamad Navab, G M Anantharamaiah, Susan Hama, et al.
Current Opinion in Lipidology|July 13, 2006
Potential clinical utility of high-density lipoprotein-mimetic peptidesMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Pageof 15

Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|July 10, 2004
Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse modelsSrinivasa T Reddy, Julie T Nguyen, Victor Grijalva, et al.
Journal of Clinical Lipidology|May 2, 2008
Peptide Mimetics of Apolipoproteins Improve HDL FunctionMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Diabetes|August 20, 2011
Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetesCecilia Morgantini, Andrea Natali, Beatrice Boldrini, et al.
Journal of Lipid Research|December 15, 2011
D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null miceMohamad Navab, Srinivasa T Reddy, G M Anantharamaiah, et al.
Nature Clinical Practice. Endocrinology & Metabolism|September 8, 2006
Mechanisms of disease: proatherogenic HDL--an evolving fieldMohamad Navab, Gattadahalli M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|October 28, 2008
Multiple indications for anti-inflammatory apolipoprotein mimetic peptidesBrian J Van Lenten, Mohamad Navab, G M Anantharamaiah, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 28, 2012
Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer modelFeng Gao, Arnab Chattopadhyay, Mohamad Navab, et al.
The Journal of Biological Chemistry|May 13, 2009
Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoproteinJunji Watanabe, Victor Grijalva, Susan Hama, et al.
Circulation|January 24, 2002
Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterolMohamad Navab, G M Anantharamaiah, Susan Hama, et al.
Current Opinion in Lipidology|July 13, 2006
Potential clinical utility of high-density lipoprotein-mimetic peptidesMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Pageof 15